OPK
Opko Health IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$913.57M
P/E Ratio
—
EPS
$-0.30
Beta
1.49
52W High
$1.60
52W Low
$1.09
50-Day MA
$1.20
200-Day MA
$1.33
Dividend Yield
—
Profit Margin
-37.20%
Forward P/E
53.76
PEG Ratio
93.65
About Opko Health Inc
OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company is headquartered in Miami, Florida.
Fundamentals
| Revenue (TTM) | $606.88M |
| Gross Profit (TTM) | $81.91M |
| EBITDA | $-127.36M |
| Operating Margin | -29.00% |
| Return on Equity | -17.10% |
| Return on Assets | -6.62% |
| Revenue/Share (TTM) | $0.81 |
| Book Value | $1.67 |
| Price-to-Book | 0.71 |
| Price-to-Sales (TTM) | 1.50 |
| EV/Revenue | 1.522 |
| EV/EBITDA | 19.94 |
| Quarterly Earnings Growth (YoY) | -12.60% |
| Quarterly Revenue Growth (YoY) | -19.20% |
| Shares Outstanding | $759.07M |
| Float | $339.45M |
| % Insiders | 49.34% |
| % Institutions | 26.88% |
Analyst Ratings
Consensus ($3.40 target)
3
Strong Buy2
Buy2
HoldData last updated: 4/9/2026